A study demonstrated that ALPL was associated with disease severity and pulmonary fibrosis (a major complication of COVID-19) in COVID-19, and by neural network modeling analysis, ALPL may be a potential biomarker for identifying the severity of COVID-19 [92]. This evidence concerns the gene ALPL and COVID-19.